57075-83-9 Usage
Uses
Used in Organic Synthesis:
2-Methoxy-benzamidine hydrochloride is used as a reagent in organic synthesis for its ability to facilitate the formation of desired chemical products through various reactions.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-Methoxy-benzamidine hydrochloride is used as an intermediate, playing a crucial role in the development and production of various drugs.
Used in Biochemical Research:
2-Methoxy-benzamidine hydrochloride is used as a research tool in biochemical studies due to its ability to inhibit the activity of serine proteases, which helps in understanding the functions and mechanisms of these enzymes.
Used in Pharmaceutical and Agrochemical Compounds Synthesis:
As a precursor, 2-Methoxy-benzamidine hydrochloride is used in the synthesis of a wide range of pharmaceutical and agrochemical compounds, contributing to the development of new and improved products in these fields.
Check Digit Verification of cas no
The CAS Registry Mumber 57075-83-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,0,7 and 5 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 57075-83:
(7*5)+(6*7)+(5*0)+(4*7)+(3*5)+(2*8)+(1*3)=139
139 % 10 = 9
So 57075-83-9 is a valid CAS Registry Number.
57075-83-9Relevant articles and documents
Macrocyclic MCL-1 inhibitors and methods of use
-
Paragraph 0534, (2019/02/28)
The present disclosure provides for compounds of Formula (I) wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents for the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of Formula (I).
MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE
-
Paragraph 00299, (2019/03/05)
The present disclosure provides for compounds of formula (I), wherein A2, A3, A4, A6, A7, A8, A15, RA, R5, R9, R10A, R10B, R11, R12, R13, R14, R16, W, X, and Y have any of the values defined in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of diseases and conditions, including cancer. Also provided are pharmaceutical compositions comprising compounds of formula (I).
